Weekly Digest – September 2026 Weekly Digest – September 2026 08 September 2026: Adlai Nortye announced the first patient dosing in Australia and U.S. FDA IND clearance for AN4035 Adlai Nortye announced that the first patient has been dosed in […]
Weekly Digest – September 2026 Weekly Digest – September 2026 04 September 2026: Acepodia announces FDA clearance of IND application for ACE723, a novel dual-payload ADC Acepodia announced that the U.S. FDA has cleared the IND application for ACE723, a […]
Weekly Digest – September 2026 Weekly Digest – September 2026 09 September 2026: InnoCare announced approval in China to initiate clinical trials of ICP-B381, a novel PSMA/STEAP1-targeting bispecific ADC InnoCare Pharma announced that China’s NMPA has approved the clinical trial […]
Weekly Digest – September 2026 Weekly Digest – September 2026 09 September 2026: Adagene announced a milestone with Exelixis supporting the advancement of SAFEbody ADC candidates Adagene announced that it has achieved a milestone under its collaboration and license agreement […]
Weekly Digest – September 2026 Weekly Digest – September 2026 08 September 2026: Cellbion and AHN-GOOK Pharmaceutical announced a collaboration for the joint development of next-generation radiopharmaceuticals Cellbion and AHN-GOOK Pharmaceutical announced a memorandum of understanding to jointly research and […]
Weekly Digest – September 2026 Weekly Digest – September 2026 08 September 2026: ITM and SpiroChem announced a strategic discovery collaboration to expand ITM’s radiopharmaceutical pipeline ITM Isotope Technologies Munich and SpiroChem announced a strategic drug discovery collaboration to advance […]
